Physician profile
Lam T Le
NPI 1063562981
$8,357.35
in general payments reported to CMS, 2019-2025
27 companies · $427 in 2025
The $427 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,942 · 2020: $1,000 · 2021: $985 · 2022: $2,318 · 2023: $1,385 · 2024: $300 · 2025: $427.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,112.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,112.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $3,428.10 | 2021-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Integra Lifesciences Corporation | $1,971.04 | 2019-2025 | Tcc-Ez |
| Organogenesis INC. | $1,136.33 | 2019-2022 | |
| Smith+Nephew, INC. | $443.51 | 2019-2025 | Collagenase Santyl |
| Abbvie INC. | $271.63 | 2021-2024 | |
| Advanced Medical Administration | $225.72 | 2025 | Amniograft |
| Inari Medical, INC. | $221.49 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Reprise Biomedical, INC. | $92.73 | 2023-2025 | Miro3d |
| Solventum Corporation | $84.08 | 2024-2025 | Activ.A.C., Promogran Prisma, 3m Cavilon |
| Mimedx Group, INC. | $61.35 | 2024 | |
| Apria Healthcare LLC | $50.75 | 2021 | |
| Paratek Pharmaceuticals, INC. | $50.12 | 2022-2024 | Nuzyra |
| Ovik Health, LLC | $42.63 | 2024-2025 | Coflex Tlc, Assist Silver |
| Kci USA, INC. | $40.68 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $28.57 | 2025 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| 3m Company | $28.04 | 2019 | |
| Osiris Therapeutics INC. | $25.46 | 2019 | |
| Polynovo North America LLC | $23.07 | 2023 | |
| Advanced Oxygen Therapy INC. | $21.60 | 2022 | |
| Bsn Medical INC | $21.00 | 2025 | |
| Averitas Pharma INC. | $17.86 | 2024 | Qutenza |
| Allergan, INC. | $17.45 | 2019 | |
| Acera Surgical, INC. | $15.37 | 2022 | |
| Convatec INC. | $14.75 | 2022 | |
| Hydrofera LLC | $14.29 | 2022 | |
| Cashflow Solutions, LLC | $9.73 | 2024 | Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lam Le listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.